SEC Form 4 · accession 0001225208-18-015843
Edwards Lifesciences Corp · EW
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Robert W.A. Sellers
Officer — VP, Corporate Controller
Period of report
Nov 20, 2018
Accepted (ET)
Nov 23, 2018 · 5:31 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001099800
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Nov 20, 2018 | M | 5,259 | $42.725 | A | 18,541 | D | |
| Common StockF1 | Nov 20, 2018 | S | 5,259 | $153.1441 | D | 13,282 | D | |
| Common Stock | Nov 21, 2018 | M | 2,600 | $42.725 | A | 15,882 | D | |
| Common StockF2 | Nov 21, 2018 | S | 2,600 | $153.1821 | D | 13,282 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Employee Stock Option (Right to Acquire) | $42.725 | Nov 20, 2018 | M | 5,259 | D | May 9, 2013 | May 8, 2019 | Common Stock | 5,259 | 3,421 | D |
| Employee Stock Option (Right to Acquire) | $42.725 | Nov 21, 2018 | M | 2,600 | D | May 9, 2013 | May 8, 2019 | Common Stock | 2,600 | 821 | D |
Explanation of responses
- F1This transaction was executed in multiple trades at prices ranging from $153.00 to $153.37. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide, upon request by the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected.
- F2This transaction was executed in multiple trades at prices ranging from $153.00 to $153.48. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide, upon request by the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected.
Remarks
This Form 4 reflects changes in beneficial ownership only; it does not identify other securities of the Issuer beneficially owned by the Reporting Person.